Tech World Maldives
SEE OTHER BRANDS

Top science and technology news from Maldives

Tech World Maldives: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech World Maldives.

Press releases published on July 1, 2025

Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032
Andvaris Appoints Mahmud Samad as Chief Financial Officer to Support Strategic Growth
JA Mining Launches Advanced Cloud Mining Platform to Democratize Profitability
Neo Pepe Coin ($NEOP) Shakes Up Crypto Space with Innovative DAO Governance Structure
Test Boost Max: This Legal Testosterone Supplement For Men Now Available in USA
Autobrush: How This U-Shaped Toothbrush Is Changing the Way Adults Clean Their Teeth – Read Autobrush Report 2025!
Cellectar Biosciences Announces Pricing of $6 Million Underwritten Public Offering
Wavetek Deploys Silvaco’s Victory TCAD™ to Drive Innovation in GaN-Based Connectivity Solutions
Maris-Tech Expands Asia-Pacific Reach with New Distribution Agreement in Singapore
Angry Pepe Fork Unveils Deflationary Roadmap
Tenant Turner Launches Zapier Integration to Meet Growing Demand for Seamless Automation
Varonis Announces Strategic Partnership with Microsoft to Help Secure the Future of AI
Check Point Software to Announce 2025 Second Quarter Financial Results on July 30, 2025
John Snow Labs Launches Martlet.ai, Setting New Standards for Risk Adjustment with Healthcare Large Language Models
Paytronix Partners with Auphan Software to Expand Canadian Footprint; Drive Interoperability for SMB Operators
First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology
Nutanix Study Finds Adoption of GenAI and Containers in the Healthcare Sector Has Accelerated, But IT Infrastructure Modernization to Support it Lags Behind
SailPoint Announces Addition to Russell 3000® Index
ServiceTitan Partners with Associated Builders and Contractors to Empower Construction Professionals
Inmagene Doses First Patient in the ADAPTIVE Phase 2b Trial of IMG-007, a Nondepleting Anti-OX40 mAb with an Extended Half-life, in Patients with Moderate-to-Severe Atopic Dermatitis

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions